These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35595639)

  • 21. Clinical pharmacy programmatic perspectives on use of direct-acting antivirals for acquired hepatitis C infection in solid organ transplant recipients.
    Crona L; Berry H; Byrns J; Campbell U
    Am J Health Syst Pharm; 2020 Jul; 77(14):1149-1152. PubMed ID: 32537658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    Winetsky D; Burack D; Antoniou P; Garcia B; Gordon P; Scherer M
    J Infect Dis; 2020 Sep; 222(Suppl 5):S392-S400. PubMed ID: 32877544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
    Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
    Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C.
    Bolduc C; McCall K; Stickney K; Gelinas A; Levesque E
    J Manag Care Spec Pharm; 2021 Feb; 27(2):263-267. PubMed ID: 33506724
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
    Schmitt A; Günther R; Mauss S; Boeker KHW; Buggisch P; Hillenbrand H; John C; Klinker H; Pathil A; Simon KG; Serfert Y; Niederau C; Vermehren J; Wedemeyer H; Sarrazin C
    Z Gastroenterol; 2020 Apr; 58(4):341-351. PubMed ID: 32040979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.
    Morris MD; Mirzazadeh A; Evans JL; Briceno A; Coffin P; Hahn JA; Page KA
    Drug Alcohol Depend; 2019 May; 198():133-135. PubMed ID: 30921649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.
    Wang Y; Rao H; Chi X; Li B; Liu H; Wu L; Zhang H; Liu S; Zhou G; Li N; Niu J; Wei L; Zhao J
    EBioMedicine; 2019 Aug; 46():227-235. PubMed ID: 31345785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
    Butt AA; Yan P; Shaikh OS; Lo Re V; Abou-Samra AB; Sherman KE
    J Hepatol; 2020 Aug; 73(2):277-284. PubMed ID: 32145260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014-2015.
    Radwan D; Cachay E; Falade-Nwulia O; Moore RD; Westergaard R; Mathews WC; Aberg J; Cheever L; Gebo KA;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):559-567. PubMed ID: 30649030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.
    Do A; Esserman DA; Krishnan S; Lim JK; Taddei TH; Hauser RG; Tate JP; Re VL; Justice AC
    J Gen Intern Med; 2020 Jul; 35(7):2025-2034. PubMed ID: 32342483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype 1 hepatitis C virus and the pharmacist's role in treatment.
    Sebhatu P; Martin MT
    Am J Health Syst Pharm; 2016 Jun; 73(11):764-74. PubMed ID: 27126832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV).
    Walker DR; Pedrosa MC; Manthena SR; Patel N; Marx SE
    Adv Ther; 2015 Nov; 32(11):1117-27. PubMed ID: 26538232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure.
    Lu M; Wu KH; Li J; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Daida YG; Schmidt MA; Rupp LB; Zhang T; Trudeau S; Gordon SC
    J Viral Hepat; 2019 Oct; 26(10):1210-1217. PubMed ID: 31197910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors.
    Smith DE; Chen S; Fargnoli A; Lewis T; Galloway AC; Kon ZN; Moazami N
    Semin Thorac Cardiovasc Surg; 2021; 33(2):407-415. PubMed ID: 32621962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting.
    Overton K; Clegg J; Pekin F; Wood J; McGrath C; Lloyd A; Post JJ
    Int J Drug Policy; 2019 Oct; 72():123-128. PubMed ID: 30967329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
    Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral PD-1
    Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
    Front Immunol; 2019; 10():1470. PubMed ID: 31316516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis.
    Cooper CL; Thavorn K; Damian E; Corsi DJ
    Ann Hepatol; 2017; 16(5):720-726. PubMed ID: 28809741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing direct-acting antivirals to treat hepatitis C virus in a general practice setting in Australia: 'so why not do it'?
    Heard E; Massi L; Smirnov A; Selvey LA
    Intern Med J; 2020 Sep; 50(9):1053-1058. PubMed ID: 31589351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.